Related references
Note: Only part of the references are listed.The pharmacist and pharmacy have evolved to become more than the corner drugstore: a win for vaccinations and public health
Angela K. Shen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Racial inequities in US naloxone prescriptions
Erin Fanning Madden et al.
SUBSTANCE ABUSE (2020)
Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access
Kathleen L. Egan et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)
Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC)
Sean F. Altekruse et al.
PLOS ONE (2020)
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018
Nana Wilson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018
Traci C. Green et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
William C. Goedel et al.
JAMA NETWORK OPEN (2020)
Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose
Rahi Abouk et al.
JAMA INTERNAL MEDICINE (2019)
Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018
Gery P. Guy et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Re-racialization of Addiction and the Redistribution of Blame in the White Opioid Epidemic
Sonia Mendoza et al.
MEDICAL ANTHROPOLOGY QUARTERLY (2019)
Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
Minji Sohn et al.
JAMA NETWORK OPEN (2019)
Opioid-overdose laws association with opioid use and overdose mortality
Chandler McClellan et al.
ADDICTIVE BEHAVIORS (2018)
Validation of a new continuous geographic isolation scale: A tool for rural health disparities research
Nathan J. Doogan et al.
SOCIAL SCIENCE & MEDICINE (2018)
Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015
Thomas J. Stopka et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2017)
Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016
Nicholas J. Somerville et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Effectiveness of Scotland's National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison
Sheila M. Bird et al.
ADDICTION (2016)
Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
Jamie K. Lim et al.
JOURNAL OF ADDICTION MEDICINE (2016)
The War on Drugs That Wasn't: Wasted Whiteness, Dirty Doctors, and Race in Media Coverage of Prescription Opioid Misuse
Julie Netherland et al.
CULTURE MEDICINE AND PSYCHIATRY (2016)
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access
Daniel P. Wermeling
THERAPEUTIC ADVANCES IN DRUG SAFETY (2015)
Disparities in Latino substance use, service use, and treatment: Implications for culturally and evidence-based interventions under health care reform
Erick G. Guerrero et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
Alexander Y. Walley et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The impact of Immigration and Customs Enforcement on immigrant health: Perceptions of immigrants in Everett, Massachusetts, USA
Karen Hacker et al.
SOCIAL SCIENCE & MEDICINE (2011)
Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies
Abby E. Rudolph et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2010)
Share Paper
